Raphael Pharmaceutical (RAPH) Change in Accured Expenses (2025)

Raphael Pharmaceutical (RAPH) posted Change in Accured Expenses of $31000.0 for Q4 2025, up 1450.0% sequentially from $2000.0 in Q3 2025.

Raphael Pharmaceutical (RAPH) Change in Accured Expenses (2025) Analysis & Trends

Raphael Pharmaceutical has reported Change in Accured Expenses for 1 years, with the latest figure at $31000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	82.00 Mn
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	142.00 Mn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-219.00 Mn
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	-4.00 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-8.50 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-	-

Download Data